EP2086940B1 — Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
Assigned to Janssen Pharmaceutica NV · Expires 2012-05-16 · 14y expired
What this patent protects
The present invention relates to the fumarate salt of (alpha S, beta R)-6-bromo-alpha- [2-(dimethylamino)ethyl] -2-methoxy-alpha- 1 -naphthalenyl-beta-phenyl-3 - quinolineethanol, pharmaceutical compositions comprising as active ingredient said salt and to processes for their pre…
USPTO Abstract
The present invention relates to the fumarate salt of (alpha S, beta R)-6-bromo-alpha- [2-(dimethylamino)ethyl] -2-methoxy-alpha- 1 -naphthalenyl-beta-phenyl-3 - quinolineethanol, pharmaceutical compositions comprising as active ingredient said salt and to processes for their preparation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.